10.- Autacoides 4

download 10.- Autacoides 4

of 20

Transcript of 10.- Autacoides 4

  • 8/14/2019 10.- Autacoides 4

    1/20

    Autos: self akos: reliefA chemical substance produced by one type of cell that affects the

    function of different types of cells in the same region .

    1. Eicosanoids: Prostaglandins (PG)Tromboxanes (TX)Leucotrienes (LT)

    2. Nitric oxide (NO) and platelet activating factor (PAF)

    3. Polipeptides: Angiotensine and Bradykinin.

    4. Amines: Histamine and serotonin

    AUTACOID

    Generatedde novo

    stored

  • 8/14/2019 10.- Autacoides 4

    2/20

    SEROTONINE5-HYDROXITRYPTAMINE

    Localization: - Enterochromaffin cells (gut) (90%)

    - platelets

    - mast cells

    - brain (1-2%)

  • 8/14/2019 10.- Autacoides 4

    3/20

    Synthesis of 5-HT

    Diet

    In enterochromaffin

    cells and neurons

  • 8/14/2019 10.- Autacoides 4

    4/20

    Monoaminooxidase

    Aldehido deshydrogenase

    5-hydroxiindolacetyc acid

    Serotonine

    Metabolism of 5-HT

    Regulation:

    Diet (tryptophan,

    tyrosine,phenylalanine,leucine)

    O2

    Daily fluctuations

    Pharmacologycal

  • 8/14/2019 10.- Autacoides 4

    5/20

    5-HT receptor subtypes

    5-HT1 (5-HT1A, 5-HT1B, 5-HT1D) CNS, blood vessels

    5-HT2 (5-HT2A, 5-HT2B, 5-HT2C) CNS and PNS, smooth

    muscle, platelets

    5-HT3 (5-HT3A, 5-HT3B) CNS, PNS

    5-HT4 CNS, PNS

    5-HT5 CNS

    5-HT6 CNS

    5-HT7 CNS, gi tract, blood

    vessels

    Distribution

  • 8/14/2019 10.- Autacoides 4

    6/20

    Pharmacological actions of 5-HT

    5-HT1A

    CNS-Inhibitory (pre andpostsynaptic)

    Anxyolisis, sleep, hyperfagia

    5-HT1D

    CNS- Inhibitory (presynaptic)

    Blood vessels- Vassoconstriction

  • 8/14/2019 10.- Autacoides 4

    7/20

    5-HT2A receptors

    Smooth muscle- contraction

    Platelets-aggregation, vassodilation/Vassoconstriction

    CNS- excitation- psicosis

    IP3, DAG

    Pharmacological actions of 5-HT

    5-HT2 receptors

  • 8/14/2019 10.- Autacoides 4

    8/20

    Pharmacological actions of 5-HT

    5-HT4

    PNS- gastrointestinal motility

    CNS- Neuronal excitation+

    5-HT3

    CNS- (area postrema) Emesis

    Anxiety

    PNS- nociceptive neurones-pain

    +

  • 8/14/2019 10.- Autacoides 4

    9/20

    Pharmacological actions of 5-HT

    5-HT6

    CNS- increases cholinergic

    transmission (memory)

    5-HT7

    CNSGi tract (Unknown)

    +

  • 8/14/2019 10.- Autacoides 4

    10/20

    5-HT storage and release in the brain

    Pharmacological actions of 5-HT

    -Mood

    -Sleep/awake cycle- Appetite

  • 8/14/2019 10.- Autacoides 4

    11/20

    5-HT and mood

  • 8/14/2019 10.- Autacoides 4

    12/20

    5-HT and weight loss

    FenfluramineandPhentermine

    Weigh

    t(kg)

    Time (weeks)

  • 8/14/2019 10.- Autacoides 4

    13/20

    5-HT in sleep-waking cycle

  • 8/14/2019 10.- Autacoides 4

    14/20

    Fluoxetine Citalopram

    ParoxetineSertraline

    Clinical use of 5-HT drugs (Antidepressants)

    SSRI (selective serotonine reuptake inhibitors)

  • 8/14/2019 10.- Autacoides 4

    15/20

    Clinical use of 5-HT drugsAnxiety 5-HT1A agonist Buspirone

    Migraine 5-HT1D agonist Sumatriptan,

    Zolmitriptan

    Migraine profilaxis 5-HT2 antagonist Dihidroergotamine

    Esquizophrenia 5-HT2A antgonist Risperidone

    Antiemetics 5-HT3 antagonist Ondansetron

    (quimiotherapy) Granisetron

    Tropisetron

    Peristaltism 5-HT4 agonists Metoclopramide

    (procinetics) Tegaserod

  • 8/14/2019 10.- Autacoides 4

    16/20

    Neurotransmitters and receptors involved in emesis control

    NEUROTRANSMITTERS

    DOPAMINE D2

    SEROTONINE 5HT3

    HISTAMINE H1

    ACETYLCHOLINE MUSCARINICS

    RECEPTORS

  • 8/14/2019 10.- Autacoides 4

    17/20

    Stimuli

    Pain,images

    Odour

    Emotions

    cinetosis

    toxins

    Stimuli from

    the gi system

    Vestibular nuclei

    H1 and M1

    Visceral afferents

    5-HT3?

    Sensory afferents

    Solitary tract

    nucleus

    H1 and M1

    Chemoreceptortrigger zone

    D2 and 5-HT3

    Vomitingcentre

    M1

    Factors involved in control of vomiting

    5-HT3 antagonists

    H1 antagonists

    D2 antagonists

    M1 antagonists

  • 8/14/2019 10.- Autacoides 4

    18/20

    ANTIEMETIC DRUGS

    D2 ANTAGONISTS

    ANTAGONISTAS 5-HT3

    ANTAGONISTAS H1

    Metoclopramide

    Domperidone

    Thietylperazine

    Haloperidol

    Ondansetron

    Granisetron

    Tropisetron

    Cinarizine

    Ciclizine

    Dimenhidrinate

  • 8/14/2019 10.- Autacoides 4

    19/20

    M1 ANTAGONISTS

    CORTICOSTEROIDS

    CANNABINOIDS

    Hioscine, escopolamine

    Nabilona

    Dexametasone

    Metilprednisolone

    ANTIEMETIC DRUGS

  • 8/14/2019 10.- Autacoides 4

    20/20

    CLINICAL USE OF ANTIEMETIC DRUGS

    D2 ANTAGONISTS

    Vomits induced by radiation, virus, pregnancy (metoclopramide)

    5-HT3 antagonists

    - Vomits induced by quimiotherapy (treatment of cancer)

    - Vomits post surgery

    - Vomits induced by radiation

    H1 antagonists

    - Motion sickness- Vestibular unbalance

    - Early morning nausea during pregnancy (doximalmine and prometacine)

    M1 antagonists

    -Motion sickness (hioscine)

    Cannabinoids

    - Vomits induced by quimiotherapy (treatment of cancer)